oranhall/iStock via Getty Images
- AbbVie (NYSE:ABBV) has broken ground on a $70M expansion of an existing site in Worcester, Mass., that serves as a biologics R&D center and manufacturing facility.
- The company said the additional space will boost its biologics manufacturing capacity. The plan also
